article thumbnail

Fellowship Training Enhances Physician-Led Laser Dermatology Care

Physician's Weekly

They performed an online search and telephone survey in September 2024 to identify board-certified dermatologists who completed an American Society for Dermatologic Surgery (ASDS) Cosmetics and Lasers Fellowship. Physician involvement in laser procedures was higher among dermatologists (60%) than plastic surgeons (33%) and medical spas (9%).

article thumbnail

Letitia Bridges, MD, MBA, appointed to chief quality officer at The Permanente Federation

Permanente Medicine

As chief quality officer at The Permanente Federation, Dr. Bridges oversees coordination of national clinical quality care programs across Kaiser Permanente for its 12.6 The Federation is the national leadership and consulting organization for Permanente Medical Groups and their more than 25,000 physicians. million members.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Oregon-based medical group Northwest Permanente announces affiliation with The Permanente Medical Group of Northern California

Permanente Medicine

Both groups have a shared mission of delivering high-quality, cost-efficient care that achieves superior clinical outcomes. By collaborating clinically, sharing innovations, and supporting physicians and staff, NWP will improve quality of care.

Medical 52
article thumbnail

Regulator and Funder? FDA’s Orphan Products Grants Program awards significant funding to help move promising treatments through clinical development

FDA Law Blog

Each year, FDA selects a limited number of clinical trials to fund to help sponsors pursue development of medical products for rare diseases and advance their field. In October, FDA announced seven new clinical trial grants awarded in fiscal year (FY) 2024 – including one for a Phase 3 trial – totaling $17.2

Clinic 69
article thumbnail

When is a Confirmatory Trial “Underway” or Conducted with “Due Diligence” Enough for Accelerated Approval? FDA Explains Its New Authorities

FDA Law Blog

Valentine We recently blogged about a new December 2024 draft guidance about accelerated approval (the December 2024 draft guidance). They also present a more intense focus on the timelines for confirmatory study initiation and completion as well as the feasibility of those studies to verify clinical benefit within those timelines.

IT 105
article thumbnail

PEMPix 2024 Online Case #4: Frozen Ever After

PEMBlog

Infantile Cortical Hyperostosis The child protection team and orthopedics were consulted due to concern for possible healing femur fracture. Clinical presentation can include subperiosteal bone hyperplasia, swelling of the overlying soft tissue as well as associated fever and irritability. Osteomyelitis D. References Glorieux FH.

article thumbnail

Using technology to reclaim our time

Today's Hospitalist

Yet this expansion has come with a significant administrative burden, particularly that of clinical documentation. This isn’t about replacing your clinical judgment. Ambient dictation, or ambient clinical documentation, represents a paradigm shift. This isn’t about replacing your clinical judgment. The result?